FindTrial
Sign In

Multimodal Neuroimaging-based Cross-site and Cross-protocol Automated Detection of Focal Cortical Dysplasia

Multimodal Neuroimaging-based Cross-site and Cross-protocol Automated Detection of Focal Cortical Dysplasia

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100046183
Enrollment
Unknown
Registered
2021-05-08
Start date
2020-01-01
Completion date
Unknown
Last updated
2021-12-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epilepsy

Interventions

Gold Standard:Underwent epilepsy surgery with pathological confirmation.
Index test:Automatic&#32
model&#32
for&#32
focal&#32
cortical&#32
dysplasia&#32
using&#32
multimodal&#32
neuroimaging&#32
and&#32
deep&#32
learning.

Sponsors

Beijing Tiantan Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Aged 6 to 60 years with diagnosis of drug-resistant epilepsy; 2. Underwent epilepsy surgery with pathological confirmation of FCD; 3. High-quality multimodal neuroimaging; 4. Patients or relatives write the consent.

Exclusion criteria

Exclusion criteria: 1. Reoperation; 2. Cognitive and psychological dysfunction; 3. Dystocia hypoxia, encephalitis or severe traumatic brain injury; 4. Other severe disease.

Design outcomes

Primary

MeasureTime frame
Youden Index;Cohen's Kappa Index;—

Countries

China

Contacts

Public ContactZhang Kai

Beijing Tiantan Hospital, Capital Medical University

zhangkai62035@sina.com+86 13501196619

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026